Insider · CIK 0001156207
Douglas B Given
Files at ARWR (ARROWHEAD PHARMACEUTICALS, INC.). First filing Dec 18, 2024, latest Dec 18, 2024.
In brief
Douglas B Given files SEC Form 4 as director at ARWR (ARROWHEAD PHARMACEUTICALS, INC.). Since Dec 18, 2024, Douglas B Given has reported 0 open-market buys worth $0 and 1 open-market sell worth $122k, the latest filed on Dec 18, 2024.
A track record needs three past buys with six months of prices behind them; Douglas B Given has 0, so none is measured yet.
The newest scored trade: sold $122k of ARWR on Dec 16, 2024, filed Dec 18, 2024, scored 20 (weak), under a 10b5-1 plan.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ARWR: ARROWHEAD PHARMACEUTICALS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | ARROWHEAD PHARMACEUTICALS, INC. | $122k 5,547 shares | -4% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Dec 17, 2024 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | 547 0.00% of outstanding | $12k | Dec 17, 2024 | $109k |
| Dec 16, 2024 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | 5,000 0.00% of outstanding | $109k | Dec 16, 2024 | none |
| Jan 11, 2024 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | 2,911 0.00% of outstanding | $107k | Jan 11, 2024 | none |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 16, 2024 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -5,000 | $21.90 | $110k | 124,714 | Dec 18, 2024 |
| Dec 17, 2024 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -547 | $22.04 | $12k | 124,167 | Dec 18, 2024 |
| Dec 15, 2023 | ARWR ARROWHEAD PHARMACEUTICALS, INC. | AGrant or award Common Stock | +14,987 | $25.41 | $381k | 132,622 | Dec 19, 2023 |
Questions about Douglas B Given
Answered from the filings on this page, as of the latest one.
Is Douglas B Given buying or selling?
Not in the last 12 months. Douglas B Given's latest open-market trade on SEC Form 4 was sold $122k of ARWR on Dec 16, 2024.
How did Douglas B Given's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Douglas B Given has 0.
Where does Douglas B Given file Form 4?
Douglas B Given has filed Form 4 at ARWR (ARROWHEAD PHARMACEUTICALS, INC.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.